| 101438-0 | CHAMPS pediatric fall risk assessment | PANEL.CLIN.RISK |
| 101439-8 | Change in mental status (qualitative) | CLIN.RISK |
| 10144-4 | T wave amplitude in lead AVR | EKG.MEAS |
| 101440-6 | History of Falls (qualitative) | CLIN.RISK |
| 101441-4 | CHAMPS pediatric fall risk assessment (qualitative) | CLIN.RISK |
| 101442-2 | Total score CHAMPS pediatric fall risk assessment | CLIN.RISK |
| 101443-0 | Soluble urokinase plasminogen activator receptor | CHEM |
| 101444-8 | Solitary lung nod malignancy risk Qualitative (qualitative, calculated.nodify xl2) | SERO |
| 101445-5 | Solitary lung nod malignancy risk Qualitative (qualitative, calculated.nodify cdt) | SERO |
| 101446-3 | Creatine kinase.MB (immunoassay) | CHEM |
| 101447-1 | Contactin-associated protein 1 Ab.IgG and Neurofascin155 Ab.IgG4 panel - Serum or Plasma | PANEL.SERO |
| 101448-9 | Contactin-associated protein 1 IgG Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 101449-7 | Neurochondrin Ab (CSF, qualitative, cell binding immunofluorescent assay) | SERO |
| 10145-1 | T wave amplitude in lead I | EKG.MEAS |
| 101450-5 | Neurochondrin Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 101451-3 | Neurochondrin Ab (CSF, qualitative, immunofluorescence) | SERO |
| 101452-1 | Neurochondrin Ab (qualitative, immunofluorescence) | SERO |
| 101453-9 | Neurochondrin Ab (CSF, immunofluorescence) | SERO |
| 101454-7 | Neurochondrin Ab (immunofluorescence) | SERO |
| 101455-4 | Mitochondrial metabolites panel - Serum or Plasma | PANEL.CHEM |
| 101456-2 | Septin-7 IgG Ab (immunofluorescence) | SERO |
| 101457-0 | Septin-7 IgG Ab (CSF, immunofluorescence) | SERO |
| 101458-8 | Septin-5 IgG Ab (immunofluorescence) | SERO |
| 101459-6 | Septin-5 IgG Ab (CSF, immunofluorescence) | SERO |
| 10146-9 | T wave amplitude in lead II | EKG.MEAS |
| 101460-4 | Septin-5 IgG Ab (qualitative, immunofluorescence) | SERO |
| 101461-2 | Septin-5 IgG Ab (CSF, qualitative, immunofluorescence) | SERO |
| 101462-0 | Septin-5 IgG Ab (CSF, qualitative, cell binding immunofluorescent assay) | SERO |
| 101463-8 | Septin-5 IgG Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 101464-6 | Septin-7 IgG Ab (CSF, qualitative, immunofluorescence) | SERO |
| 101465-3 | Septin-7 IgG Ab (qualitative, immunofluorescence) | SERO |
| 101466-1 | Septin-7 IgG Ab (CSF, qualitative, cell binding immunofluorescent assay) | SERO |
| 101467-9 | Septin-7 IgG Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 101468-7 | Risk adjustment coding gap report Document | DOC.MISC |
| 101469-5 | HBA1+2 gene FIL deletion (Blood, qualitative, molecular genetics method) | MOLPATH.DEL |
| 10147-7 | T wave amplitude in lead III | EKG.MEAS |
| 101470-3 | HBA1+2 gene THAI deletion (Blood, qualitative, molecular genetics method) | MOLPATH.DEL |
| 101471-1 | Alpha globin gene deletion panel - Blood | PANEL.MOLPATH |
| 101472-9 | Catalase (Urine, qualitative) | MICRO |
| 101473-7 | Gas and electrolytes panel - Venous blood | PANEL.CHEM |
| 101474-5 | Adenovirus DNA and Human Metapneumovirus and Rhinovirus RNA panel - Respiratory specimen (naa with probe detection) | PANEL.MICRO |
| 101475-2 | Creatinine (Venous Blood) | CHEM |
| 101476-0 | Fasting glucose (Venous Blood) | CHAL |
| 101477-8 | Ampicillin (mic.voc detection in positive blood culture) | ABXBACT |
| 101478-6 | Ampicillin+Sulbactam (mic.voc detection in positive blood culture) | ABXBACT |
| 101479-4 | Cefotaxime (mic.voc detection in positive blood culture) | ABXBACT |
| 10148-5 | T wave amplitude in lead V1 | EKG.MEAS |
| 101480-2 | Cefotaxime+Clavulanate (mic.voc detection in positive blood culture) | ABXBACT |
| 101481-0 | cefTAZidime (mic.voc detection in positive blood culture) | ABXBACT |
| 101482-8 | cefTAZidime+Clavulanate (mic.voc detection in positive blood culture) | ABXBACT |